Abstract
Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Central Nervous System Agents in Medicinal Chemistry
Title: Regulatory T Cells in Central Nervous System: in Health and Disease
Volume: 10 Issue: 4
Author(s): Brenda Saenz, Jesus Perez-H and Anahi Chavarria
Affiliation:
Keywords: Brain tumor, central nervous system, cerebral vascular diseases, experimental autoimmune encephalomyelitis, multiple sclerosis, neuroinflammation, regulatory T cells, central nervous system (CNS), glucocorticoid-induced TNF receptor (GITR), antigen presenting cells (APC), Tr1 Regulatory Cells, neurodegenerative disorders, antiproliferative action, experimental autoimmune encephalomyelitis (EAE), autoimmune encephalomyelitis, acetylcholine, glutamate, serotonin, vascular disease, microglia activation, brain tumors, glioblastoma multiforme, heme oxygenase-1 (HO-1), neoangiogenesis, cerebral malaria (ECM), Cytotoxic T lymphocyte-associated antigen 4, Glucocorticoid-induced TNF receptor, Major histocompatibility complex class II
Abstract: Regulatory T cells participate in several immune responses including autoimmune reactions inducing selftolerance, tumor immunity, transplantation tolerance and microbial infection. Nevertheless, regulatory T cells actions seem to be different when they are in the central nervous system (CNS), since they interact with resident cells of the CNS, according to the particular conditions elicited in this compartment. This review focuses on the role of regulatory T cells in health, autoimmune and other CNS diseases, pointing out their interactions with resident CNS cells.
Export Options
About this article
Cite this article as:
Saenz Brenda, Perez-H Jesus and Chavarria Anahi, Regulatory T Cells in Central Nervous System: in Health and Disease, Central Nervous System Agents in Medicinal Chemistry 2010; 10 (4) . https://dx.doi.org/10.2174/187152410793429674
DOI https://dx.doi.org/10.2174/187152410793429674 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of microRNA in Ischemic and Hemorrhagic Stroke
Current Drug Delivery Alkaloid-Metal Based Anticancer Agents
Current Topics in Medicinal Chemistry Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Tachykinins and their Receptors in Human Malignancies
Current Drug Targets The Functional Role of Oncogenic LncRNA BCAR4 for Cancer Outcome
Current Pharmaceutical Design Lipid Based Nanoparticles as Inherent Reversing Agents of Multidrug Resistance in Cancer
Current Pharmaceutical Design Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Network Pharmacology and Reverse Molecular Docking-Based Prediction of the Molecular Targets and Pathways for Avicularin Against Cancer
Combinatorial Chemistry & High Throughput Screening Subdural Pharmacotherapy for the Treatment of Intractable Focal Neocortical Epilepsy
Drug Delivery Letters Rho GTPase Activating Proteins in Cancer Phenotypes
Current Protein & Peptide Science Amyloid Beta Peptide 1-40 Stimulates the Na+ / Ca2+ Exchange Activity of SNCX
Current Neurovascular Research The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy
Current Cancer Drug Targets Current Non-viral Gene Therapy Strategies for the Treatment of Glioblastoma
Current Medicinal Chemistry Antitumor Activity and Structure-Activity Relationship of Diterpenoids with a Dehydroabietyl Skeleton
Combinatorial Chemistry & High Throughput Screening Intracellular Trafficking Mechanism and Cytosolic Protein Interactions of a Non Viral Gene Delivery Vector: Studies Based on Transferrin Conjugated Pullulan-PEI
Current Nanoscience Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Current Cancer Drug Targets Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets